Andreessen Horowitz (a16z) is showing less interest in digital health nowadays.
The prominent VC went from participating in 20 deals (worth $2.8B in total) in 2021 to just 10 deals (worth $341M) in 2022. In 2023 so far, the firm has only participated in 3 digital health deals (worth $120M).
Andreessen Horowitz’s reduced digital health investment reflects a more challenging funding environment for startups — with investors far less inclined to back mid- and late-stage deals at the sky-high valuations that were common during 2021’s funding boom.
Want the full post? Become a CB Insights customer.
If you’re already a customer, log in here.
The post Andreessen Horowitz is pulling back on digital health, but care delivery and wellness tech remain priorities appeared first on CB Insights Research.
More Stories
Daily Blog #681: DFIR Discord by Andrew Rathbun
Check Point Announces Quantum DDoS Protector X Series with Advanced SecOps Capabilities
Azure Virtual WAN security is enhanced by Check Point CloudGuard, now Generally Available